NanoVibronix, Inc. (NAOV)
NASDAQ: NAOV · Real-Time Price · USD
0.8556
-0.3244 (-27.49%)
At close: May 28, 2025, 4:00 PM
1.410
+0.554 (64.80%)
Pre-market: May 29, 2025, 6:01 AM EDT
NanoVibronix Employees
NanoVibronix had 31 employees as of December 31, 2024. The number of employees increased by 15 or 93.75% compared to the previous year.
Employees
31
Change (1Y)
15
Growth (1Y)
93.75%
Revenue / Employee
$85,871
Profits / Employee
-$181,032
Market Cap
2.21M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
NAOV News
- 13 hours ago - NanoVibronix Responds to False Post - Business Wire
- 22 hours ago - Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures - Business Wire
- 12 days ago - NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants - Business Wire
- 13 days ago - NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants - Business Wire
- 16 days ago - NanoVibronix Announces Results from UroShield™ Case Series - Business Wire
- 6 weeks ago - NanoVibronix Regains Nasdaq Compliance - Business Wire
- 2 months ago - NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia - Business Wire
- 2 months ago - Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal - Business Wire